儿童喘生物疗法的进展:新兴疗法和未来方向
Pablo Xavier Anda Suárez1, Uziel Márquez Romero2, Nayely García Méndez3
1Primary and Outpatient Care, Universidad de Las Américas, Quito, ECU.
Cureus
|June 9, 2025
概括
生物疗法正在推进个性化重症儿科喘治疗,特别是T2高的炎症. 对于其他喘类型,需要新的治疗方法,强调精准医学和生物标志物发现,以获得更好的结果.
科学领域:
- 儿科肺病学 儿科肺病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的儿科喘管理仍然具有挑战性,T2高的炎症是当前生物疗法的关键目标.
- 了解喘内型和生物标志物进展对于开发有效的个性化治疗至关重要.
研究的目的:
- 审查儿童喘的生物治疗方法,重点关注它们对T2高炎症的影响.
- 分析像奥马利祖马布,梅波利祖马布和杜比卢马布这样的生物药物的疗效和安全性.
- 探索严重儿科喘的新兴治疗机会和精准医学方法.
主要方法:
- 关于儿童喘生物治疗的最新研究的综合文献综述.
- 分析与治疗反应相关的生物标志物进步和内型模式.
- 检查已批准和新兴生物制剂的临床试验数据和安全概况.
主要成果:
- 生物药物 (奥马利祖马布,梅波利祖马布,杜比卢马布,本拉利祖马布,特泽佩卢马布) 在减少T2高的儿科喘恶化方面表现有前景,短期安全性良好.
- 目前的生物药物在T2-低和非T2喘中有效性有限,这凸显了对新型治疗点的需求.
- 精准医学,多种药物数据和新型生物标志物正在改善患者选择和治疗量身定制.
结论:
- 生物疗法的进步为个性化重症儿科喘治疗提供了显著的进步,特别是T2高的内型.
- 针对非T2内型的生物药物的进一步研究和开发是必不可少的.
- 整合精准医学和奥米克斯数据有可能彻底改变儿科喘管理,改善生活质量和减少皮质类固醇依赖.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
249
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
249
01:17Drugs Used in Lower Respiratory Disorders: Overview
358
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358
01:20Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
226
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
226